Pharmaceutical intermediates
Suzetrigine Intermediates
10 pharmaceutical intermediates for Suzetrigine. Indication: Pain.
About Suzetrigine
- Originator
- Vertex Pharmaceuticals Inc
- Indication
- Pain
- Approved Date
- 01/30/2025
- NCE Patent
- 01/30/2030
- DS/DP
- 12/04/2040
Available intermediates
10 intermediates currently listed for Suzetrigine. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 3,4-Difluoro-2-methoxyphenylacetic acid | 1558274-26-2 | / | / |
| (R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPIONIC ACID | 44864-47-3 | / | / |
| Methyl 4-aminopyridine-2-carboxylate | 71469-93-7 | / | / |
| 2-Butanone, 4,4,4-trifluoro-3-hydroxy-3-methyl-, (3R)- | 2875067-31-3 | / | / |
| 2-Furancarboxylic acid, 3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-, (2R,3S,4S,5R)- | 2649470-87-9 | / | / |
| (2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxylic acid (R)-1-phenylethan-1-amine salt | 2649470-89-1 | / | / |
| (2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carbonitrile | 2875067-17-5 | / | / |
| 2(5H)-Furanone, 3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)-, (5R)- | 2875066-35-4 | / | / |
| Methyl 4-[[[(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]-2-pyridinecarboxylate | 2879218-02-5 | / | / |
| 2-Pyridinecarboxamide, 4-[[[(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]- | 2649467-58-1 | / | / |
Building toward Suzetrigine?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →